{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:48:54Z","timestamp":1791834534787,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["2P01 AR-05235"],"award-info":[{"award-number":["2P01 AR-05235"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010897","name":"Newton Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013529","name":"National Lottery Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013529","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bja.2026.08.048","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:55:23Z","timestamp":1790121323000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology of malignant hyperthermia in the UK from 1988 to 2025: implications for prevalence, mode of inheritance, relative risk associated with RYR1 genotypes, and in vitro contracture test phenotyping"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4651-5806","authenticated-orcid":false,"given":"Essameldeen M.","family":"Aboelsaod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickla","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8704-4297","authenticated-orcid":false,"given":"Huw","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8427-1159","authenticated-orcid":false,"given":"Pawan K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Bilmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0192-3798","authenticated-orcid":false,"given":"Sarah","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1710-1751","authenticated-orcid":false,"given":"Rachel L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2084-5727","authenticated-orcid":false,"given":"Marie-Anne","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8127-1739","authenticated-orcid":false,"given":"Philip M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2026.08.048_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bja.2025.11.006","article-title":"European Malignant Hyperthermia Group 2025 guidelines for the investigation of malignant hyperthermia susceptibility","volume":"136","author":"R\u00fcffert","year":"2026","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/anae.15317","article-title":"Malignant hyperthermia 2020: guideline from the Association of Anaesthetists","volume":"76","author":"Hopkins","year":"2021","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2026.08.048_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bja.2024.09.022","article-title":"Recognition and management of a malignant hyperthermia crisis: updated 2024 guideline from the European Malignant Hyperthermia Group","volume":"134","author":"Glahn","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","article-title":"Anaesthetic deaths in a family","volume":"34","author":"Denborough","year":"1962","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","article-title":"Genetic epidemiology of malignant hyperthermia in the UK","volume":"121","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bja.2023.04.014","article-title":"What is malignant hyperthermia susceptibility?","volume":"131","author":"Hopkins","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(70)92069-6","article-title":"Metabolic error of muscle metabolism after recovery from malignant hyperthermia","volume":"2","author":"Kalow","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.bja.2026.08.048_bib8","first-page":"721","article-title":"Halothane-induced muscle contracture as a cause of hyperpyrexia","volume":"43","author":"Ellis","year":"1971","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group","volume":"41","author":"Ording","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bja.2026.08.048_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","article-title":"Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia","volume":"343","author":"MacLennan","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bja.2026.08.048_bib12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/343562a0","article-title":"Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2","volume":"343","author":"McCarthy","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bja.2026.08.048_bib13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/hmg\/6.6.953","article-title":"A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees","volume":"6","author":"Robinson","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bja.2026.08.048_bib14","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-021-01125-w","article-title":"Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility","volume":"23","author":"Johnston","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.bja.2026.08.048_bib15","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1093\/hmg\/ddac145","article-title":"Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility","volume":"31","author":"Johnston","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bja.2026.08.048_bib16","first-page":"1334","article-title":"Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene","volume":"56","author":"Deufel","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2026.08.048_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1399-0004.1997.tb02561.x","article-title":"Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutation","volume":"52","author":"Fagerlund","year":"1997","journal-title":"Clin Genet"},{"key":"10.1016\/j.bja.2026.08.048_bib18","first-page":"833","article-title":"The G1021A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia susceptibility in a British pedigree","volume":"60","author":"Adeokun","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2026.08.048_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejhg.5200964","article-title":"Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?","volume":"11","author":"Robinson","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.bja.2026.08.048_bib20","series-title":"The Report of the National Confidential Enquiry into Perioperative Deaths 1990. London","author":"Campling","year":"1992"},{"key":"10.1016\/j.bja.2026.08.048_bib22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0277-9536(93)90332-X","article-title":"Caesarean section in Britain and the United States 12% or 24%: is either the right rate?","volume":"37","author":"Francome","year":"1993","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.bja.2026.08.048_bib23","first-page":"cc89","volume":"604","year":"1999"},{"key":"10.1016\/j.bja.2026.08.048_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bmj.298.6668.243","article-title":"Role of the private sector in elective surgery in England and Wales, 1986","volume":"298","author":"Nicholl","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2026.08.048_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/bja\/aeu292","article-title":"The state of UK anaesthesia: a survey of National Health Service activity in 2013","volume":"113","author":"Sury","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/bja\/aeq339","article-title":"National census of airway management techniques used for anaesthesia in the UK: first phase of the fourth National Audit Project at the Royal College of Anaesthetists","volume":"106","author":"Woodall","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bja.2018.04.010","article-title":"An observational national study of anaesthetic workload and seniority across the working week and weekend in the UK in 2016: the 6th National Audit Project (NAP6) Activity Survey","volume":"121","author":"Kemp","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/anae.15989","article-title":"Patient characteristics, anaesthetic workload and techniques in the UK: an analysis from the 7th National Audit Project (NAP7) activity survey","volume":"78","author":"Kane","year":"2023","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2026.08.048_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/bja\/aep204","article-title":"Genetic variation in RYR1 and malignant hyperthermia phenotypes","volume":"103","author":"Carpenter","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2026.08.048_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.mpaic.2008.04.010","article-title":"Malignant hyperthermia","volume":"9","author":"Hopkins","year":"2008","journal-title":"Anaesth Intensive Care Med"},{"key":"10.1016\/j.bja.2026.08.048_bib33","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1213\/ane.0b013e3181ac1548","article-title":"Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001\u20132005","volume":"109","author":"Brady","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2026.08.048_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/bjaed\/mkw079","article-title":"Diagnosis and management of malignant hyperthermia","volume":"17","author":"Gupta","year":"2017","journal-title":"BJA Educ"},{"key":"10.1016\/j.bja.2026.08.048_bib35","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/ALN.0000000000002813","article-title":"An assessment of penetrance and clinical expression of malignant hyperthermia in individuals carrying diagnostic ryanodine receptor 1 gene mutations","volume":"131","author":"Ibarra Moreno","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2026.08.048_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.bja.2026.08.048_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bja.2026.08.048_bib38","series-title":"Ethnic group, England and Wales: census","year":"2021"},{"key":"10.1016\/j.bja.2026.08.048_bib39","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2026.08.048_bib40","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","article-title":"Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia","volume":"27","author":"Galli","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bja.2026.08.048_bib41","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/bja\/aep061","article-title":"Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases","volume":"102","author":"Broman","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib42","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12630-011-9494-6","article-title":"Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population","volume":"58","author":"Kraeva","year":"2011","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2026.08.048_bib43","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1213\/ANE.0b013e31828a71ff","article-title":"Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States","volume":"116","author":"Brandom","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2026.08.048_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0310057X1504300204","article-title":"Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families","volume":"43","author":"Gillies","year":"2015","journal-title":"Anaesth Intensive Care"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091226007166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091226007166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:18:36Z","timestamp":1791832716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091226007166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S0007091226007166"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2026.08.048","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of malignant hyperthermia in the UK from 1988 to 2025: implications for prevalence, mode of inheritance, relative risk associated with RYR1 genotypes, and in vitro contracture test phenotyping","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2026.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}